Lower Perfusion Pressure during Hypothermic Cardiopulmonary Bypass Is Associated with Decreased Cerebral Blood Flow and Impaired Memory Performance 6 Months Postoperatively
Objectives: We undertook to determine the influence of perfusion pressure during hypothermic cardiopulmonary bypass (CPB) on cerebral blood flow (CBF) and cognitive memory outcome at 6 months postoperatively.
Methods: Nineteen patients who underwent hypothermic nonpulsatile CPB for elective coronary artery bypass (CAB) surgery were evaluated by 133Xe measurement of the CBF and by the Incidental Memory Assessment for evaluating cognitive memory (IMTscore), both at baseline before the operation (T1) and again at 5 to 6 months postoperatively (T2).
Results: Overall, the mean CBF fell significantly from 39 ± 5 mL·(100 g)-1·min-1 at T1 to 33 ± 3 mL·(100 g)-1·min-1 at T2 (P < .001). The decrease in CBF from T1 to T2 (?CBF2-1) correlated with a significant reduction in the IMTscore from T1 to T2 (?IMTscore2-1) (P < .001) and with a mean arterial pressure during CPB (MAPCPB) of <60 mm Hg (P = .05). Cluster analysis of ?CBF2-1 and ?IMTscore2-1 demonstrated that the patients with the greatest decrease in CBF showed the greatest decrease in IMTscore, whereas cluster analysis of ?CBF2-1 and MAPCPB indicated that patients with a perfusion pressure maintained at a mean of <60 mm Hg during CPB were prone to a greater decrease in later postoperative CBF.
Conclusion: This study demonstrated that a MAPCPB of <60 mm Hg during CPB was associated with a significant decrease in CBF 6 months after CAB surgery and with an associated decrease in memory performance.
Bokeriia LA, Golukhova EZ, Polunina AG. 2009. Postoperative delirium in cardiac operations: microembolic load is an important factor. Ann Thorac Surg 88:349-50.nChernov VI, Efimova NY, Efimova IY, Akhmedov SD, Lishmanov YB. 2006. Short-term and long-term cognitive function and cerebral perfusion in off-pump and on-pump coronary artery bypass patients. Eur J Cardiothorac Surg 29:74-81.nChock VY, Amir G, Davis CR, et al. 2006. Antegrade cerebral perfusion reduces apoptotic neuronal injury in a neonatal piglet model of cardiopulmonary bypass. J Thorac Cardiovasc Surg 131:659-65.nD'Ancona G, Saez de Ibarra JI, Baillot R, et al. 2003. Determinants of stroke after coronary artery bypass grafting. Eur J Cardiothorac Surg 24:552-6.nden Uil CA, Lagrand WK, Spronk PE, et al. 2008. Impaired sublingual microvascular perfusion during surgery with cardiopulmonary bypass: a pilot study. J Thorac Cardiovasc Surg 136:129-34.nGerriets T, Schwarz N, Sammer G, et al. 2009. Protecting the brain from gaseous and solid micro-emboli during coronary artery bypass grafting: a randomized controlled trial. Eur Heart J. In press.nGold JP, Charlson ME, Williams-Russo P, et al. 1995. Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg 110:1302-14.nHenriksen L. 1984. Evidence suggestive of diffuse brain damage following cardiac operations. Lancet 1:816-20.nKnipp SC, Matatko N, Wilhelm H, et al. 2008. Cognitive outcomes three years after coronary artery bypass surgery: relation to diffusion-weighted magnetic resonance imaging. Ann Thorac Surg 85:872-9.nMeyers CA, Weitzner M, Byrne K, Valentine A, Champlin RE, Przepiorka D. 1994. Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. J Clin Oncol 1994:12:820-36.nMurkin JM. 2006. Pathophysiological basis of CNS injury in cardiac surgical patients: detection and prevention. Perfusion 21:203-8.nMurkin JM, Farrar JK, Tweed WA, McKenzie FN, Guiraudon G. 1987. Cerebral autoregulation and flow/metabolism coupling during cardiopulmonary bypass: the influence of PaCO2. Anesth Analg 66:825-32.nMurkin JM, Martzke JS, Buchan AM, Bentley C, Wong CJ. 1995. A randomized study of the influence of perfusion technique and pH management strategy in 316 patients undergoing coronary artery bypass surgery. II. Neurologic and cognitive outcomes. J Thorac Cardiovasc Surg 110:349-62.nNewman MF, Croughwell ND, Blumenthal JA, et al. 1994. Effect of aging on cerebral autoregulation during cardiopulmonary bypass. Association with postoperative cognitive dysfunction. Circulation 90:II243-9.nNewman MF, Kirchner JL, Phillips-Bute B, et al., for the Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. 2001. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 344:395-402.nNishimura T, Fukuchi K, Hayashida K, Hirose Y, Iwamoto B. 1998. Decreased hippocampal blood flow related to memory impairment after cardiovascular surgery: assessment by reconstructed SPECT parallel to the longitudinal axis of the hippocampal formations. Clin Nucl Med 23:356-60.nPloch W, Cook DJ, Orszulak TA, Daly RC. 1998. Critical cerebral perfusion pressure during tepid heart operation in dogs. Ann Thorac Surg 66:118-23.nSato Y, Laskowitz DT, Bennett ER, Newman MF, Warner DS, Grocott HP. 2002. Differential cerebral gene expression during cardiopulmonary bypass in the rat: evidence for apoptosis? Anesth Analg 94:1389-94.nSchwartz AE, Sandhu AA, Kaplon RJ, et al. 1995. Cerebral blood flow is determined by arterial pressure and not cardiopulmonary bypass flow rate. Ann Thorac Surg 60:165-9.nSelnes OA, Grega MA, Bailey MM, et al. 2007. Neurocognitive outcomes 3 years after coronary artery bypass graft surgery: a controlled study. Ann Thorac Surg 84:1885-96.nShann KG, Likosky DS, Murkin JM, et al. 2006. An evidence-based review of the practice of cardiopulmonary bypass in adults: a focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg 132:283-90.nTreasure T, Smith PLC, Newman S, et al. 1989. Impairment of cerebral function following cardiac and other major surgery. Eur J Cardiothorac Surg 3:216-21.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).